> QT/QTc prolongation is expected during treatment with ARSENIC TRIOXIDE, and torsade de pointes and complete heart block have been reported. Patients who are receiving, or who have received, medicinal products known to cause hypokala emia or hypomagnesaemia, such as DIURETICS or amphotericin  B, may be at higher risk for torsade de pointes. Caution is advised when ARSENIC TRIOXIDE MEDAC is coadministered with other medicinal products known to cause QT/QTc interval prolongation such as macrolide ANTIBIOTICS, the antipsychotic THIORIDAZINE, or medicinal products known to cause hypokalaemia or hypomagnesaemia. Additional information about QT prolonging medicinal agents, is provided in section  4.4. 8  Medicinal products known to cause hepatotoxic effects
